PT1173436E - Derivado de tiazolidinodiona e sua utilizacao como antidiabetico - Google Patents

Derivado de tiazolidinodiona e sua utilizacao como antidiabetico

Info

Publication number
PT1173436E
PT1173436E PT00920893T PT00920893T PT1173436E PT 1173436 E PT1173436 E PT 1173436E PT 00920893 T PT00920893 T PT 00920893T PT 00920893 T PT00920893 T PT 00920893T PT 1173436 E PT1173436 E PT 1173436E
Authority
PT
Portugal
Prior art keywords
thiazolidinodiona
antidiabetic
derived
Prior art date
Application number
PT00920893T
Other languages
English (en)
Inventor
Robert Gordon Giles
Paul David James Blackler
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT1173436E publication Critical patent/PT1173436E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PT00920893T 1999-04-20 2000-04-19 Derivado de tiazolidinodiona e sua utilizacao como antidiabetico PT1173436E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
PT1173436E true PT1173436E (pt) 2004-10-29

Family

ID=10851901

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00920893T PT1173436E (pt) 1999-04-20 2000-04-19 Derivado de tiazolidinodiona e sua utilizacao como antidiabetico

Country Status (42)

Country Link
EP (2) EP1173436B1 (pt)
JP (2) JP4283449B2 (pt)
KR (1) KR100601244B1 (pt)
CN (2) CN1327447A (pt)
AP (1) AP1562A (pt)
AR (2) AR023566A1 (pt)
AT (1) ATE268770T1 (pt)
AU (2) AU4130900A (pt)
BG (1) BG65864B1 (pt)
BR (1) BR0009897A (pt)
CA (1) CA2382036A1 (pt)
CO (1) CO5170422A1 (pt)
CZ (1) CZ300653B6 (pt)
DE (1) DE60011419T2 (pt)
DK (1) DK1173436T3 (pt)
DZ (1) DZ3162A1 (pt)
EA (1) EA004232B1 (pt)
EG (1) EG24063A (pt)
ES (1) ES2218146T3 (pt)
GB (1) GB9909041D0 (pt)
HK (1) HK1045151B (pt)
HR (1) HRP20010770B1 (pt)
HU (1) HUP0200865A3 (pt)
IL (1) IL146078A0 (pt)
MA (1) MA26783A1 (pt)
MX (1) MXPA01010696A (pt)
MY (1) MY126034A (pt)
NO (1) NO320609B1 (pt)
NZ (1) NZ515166A (pt)
OA (1) OA11866A (pt)
PE (1) PE20010050A1 (pt)
PL (1) PL351135A1 (pt)
PT (1) PT1173436E (pt)
RS (1) RS50136B (pt)
SI (1) SI1173436T1 (pt)
SK (1) SK284991B6 (pt)
TR (1) TR200103040T2 (pt)
TW (1) TWI277616B (pt)
UA (1) UA71615C2 (pt)
UY (1) UY26112A1 (pt)
WO (1) WO2000063205A2 (pt)
ZA (1) ZA200108720B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
AU2002343050A1 (en) * 2001-11-21 2003-06-10 Smithkline Beecham P.L.C. 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ2004844A3 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
OA11866A (en) 2006-03-02
SK14902001A3 (sk) 2002-02-05
HRP20010770A2 (en) 2002-10-31
EA004232B1 (ru) 2004-02-26
CO5170422A1 (es) 2002-06-27
SI1173436T1 (en) 2004-12-31
BR0009897A (pt) 2002-04-16
TWI277616B (en) 2007-04-01
ATE268770T1 (de) 2004-06-15
UY26112A1 (es) 2000-12-29
PE20010050A1 (es) 2001-03-10
NO320609B1 (no) 2005-12-27
NO20015104D0 (no) 2001-10-19
WO2000063205A3 (en) 2001-01-25
RS50136B (sr) 2009-03-25
CN1327447A (zh) 2001-12-19
BG106112A (bg) 2002-05-31
BG65864B1 (bg) 2010-03-31
KR20010110791A (ko) 2001-12-13
EP1411055A1 (en) 2004-04-21
MA26783A1 (fr) 2004-12-20
CN101134756A (zh) 2008-03-05
DE60011419D1 (de) 2004-07-15
NZ515166A (en) 2004-02-27
EP1173436A2 (en) 2002-01-23
HK1045151B (zh) 2005-03-18
UA71615C2 (uk) 2004-12-15
IL146078A0 (en) 2002-07-25
JP2002542242A (ja) 2002-12-10
PL351135A1 (en) 2003-03-24
JP4283449B2 (ja) 2009-06-24
HUP0200865A2 (en) 2002-08-28
WO2000063205A2 (en) 2000-10-26
GB9909041D0 (en) 1999-06-16
SK284991B6 (sk) 2006-04-06
AU2755202A (en) 2002-05-16
HK1045151A1 (en) 2002-11-15
CA2382036A1 (en) 2000-10-26
KR100601244B1 (ko) 2006-07-19
AU4130900A (en) 2000-11-02
HRP20010770B1 (en) 2005-06-30
YU81501A (sh) 2004-07-15
AR023562A1 (es) 2002-09-04
TR200103040T2 (tr) 2002-04-22
DE60011419T2 (de) 2005-06-16
ZA200108720B (en) 2002-11-28
AP2001002331A0 (en) 2000-04-19
ES2218146T3 (es) 2004-11-16
EA200101101A1 (ru) 2002-04-25
DZ3162A1 (fr) 2000-10-26
JP2009143954A (ja) 2009-07-02
MY126034A (en) 2006-09-29
NO20015104L (no) 2001-12-19
AU765911B2 (en) 2003-10-02
MXPA01010696A (es) 2002-06-04
HUP0200865A3 (en) 2005-04-28
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
EP1173436B1 (en) 2004-06-09
AR023566A1 (es) 2002-09-04
CZ20013759A3 (cs) 2002-05-15
AP1562A (en) 2006-02-01
DK1173436T3 (da) 2004-09-27

Similar Documents

Publication Publication Date Title
EE200200273A (et) Uudsed diabeedivastased agensid
ID26056A (id) Popok sekali pakai
DE60024000D1 (de) Lanzette
ID26389A (id) Popok sekali pakai
DE60009395D1 (de) Bildanzeige
DE50007846D1 (de) Dreschkorb
DE60023162D1 (de) Stethoskop
DE60015351D1 (de) Lanzette
ES1047774Y (es) Estructura de electrodo
DE60019672D1 (de) Flacher Fussschalter
PT1218009E (pt) Grandulos de quetiapina
PT1218096E (pt) Microcapsulas de libertacao variavel
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
DE60011330D1 (de) Elektrode
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
NO993262D0 (no) Avl°pssystem
PT1214302E (pt) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase
PT1235566E (pt) Formulacao injectavel de valnemulina
PT1173436E (pt) Derivado de tiazolidinodiona e sua utilizacao como antidiabetico
PT1173437E (pt) Derivado de tiazolidinodiona e sua utilizacao como antidiabetico
ITMI991895A0 (it) Depigmentanti cutanei
DE29905902U1 (de) Preßkolben
PT1200409E (pt) Derivados de isoquinolina substituida e a sua utilizacao como anticonvulsivos
ID30307A (id) Potensiator-potensiator neurotrofin